{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:42:31Z","timestamp":1792608151990,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.heliyon.2024.e36880","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T07:37:35Z","timestamp":1724485055000},"page":"e36880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Case report: Antisynthetase syndrome with positive anti-PL7\/SSA\/RO52 antibodies"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7759-647X","authenticated-orcid":false,"given":"Peng","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijia","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunlan","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e36880_bib1","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijbiomac.2017.12.157","article-title":"Aminoacyl-tRNA synthetases: structure, function, and drug discovery","volume":"111","author":"Rajendran","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.heliyon.2024.e36880_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.866087","article-title":"Aminoacyl-tRNA synthetases: on anti-synthetase syndrome and beyond","volume":"13","author":"Galindo-Feria","year":"2022","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e36880_bib3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.55563\/clinexprheumatol\/8xj0b9","article-title":"Defining anti-synthetase syndrome: a systematic literature review","volume":"40","author":"Zanframundo","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36880_bib4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.semarthrit.2020.09.020","article-title":"Antisynthetase syndrome - much more than just a myopathy","volume":"51","author":"Opinc","year":"2021","journal-title":"Semin. Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e36880_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2020.101503","article-title":"Clinical manifestations and treatment of antisynthetase syndrome","volume":"34","author":"Marco","year":"2020","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e36880_bib6","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?","volume":"138","author":"Connors","year":"2010","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36880_bib7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1590\/S1806-37132011000100015","article-title":"Myositis-related interstitial lung disease and antisynthetase syndrome","volume":"37","author":"Solomon","year":"2011","journal-title":"J. Bras. Pneumol."},{"issue":"136","key":"10.1016\/j.heliyon.2024.e36880_bib8","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1183\/16000617.00002015","article-title":"Idiopathic inflammatory myopathies and the lung","volume":"24","author":"Lega","year":"2015","journal-title":"Eur. Respir. Rev."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36880_bib9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Lundberg","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e36880_bib10","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies","volume":"75","author":"Mariampillai","year":"2018","journal-title":"JAMA Neurol."},{"issue":"5 Suppl 1","key":"10.1016\/j.heliyon.2024.e36880_bib11","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1590\/0004-282x-anp-2022-s131","article-title":"Inflammatory myopathies: an update for neurologists","volume":"80","author":"Silva","year":"2022","journal-title":"Arq Neuropsiquiatr"},{"issue":"Suppl 2","key":"10.1016\/j.heliyon.2024.e36880_bib12","doi-asserted-by":"crossref","first-page":"ii10","DOI":"10.1093\/rap\/rkab054","article-title":"Clinical profile and treatment outcomes in antisynthetase syndrome: a tertiary centre experience","volume":"5","author":"Sreevilasan","year":"2021","journal-title":"Rheumatol Adv Pract"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e36880_bib13","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ejim.2013.01.002","article-title":"Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome","volume":"24","author":"Marie","year":"2013","journal-title":"Eur. J. Intern. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e36880_bib14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MD.0b013e318260977c","article-title":"Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature","volume":"91","author":"Labirua-Iturburu","year":"2012","journal-title":"Medicine (Baltim.)"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e36880_bib15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/MCP.0000000000001000","article-title":"Myositis-associated interstitial lung disease","volume":"29","author":"Vu","year":"2023","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.heliyon.2024.e36880_bib16","first-page":"kead671","article-title":"Clinical heterogeneity and prognostic factors of anti-synthetase syndrome: a multi-centered retrospective cohort study","author":"Tang","year":"2023","journal-title":"Rheumatology"},{"issue":"21","key":"10.1016\/j.heliyon.2024.e36880_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12216849","article-title":"Clinical characteristics of anti-synthetase syndrome and variables associated with interstitial lung disease and mortality: a retrospective cohort study","volume":"12","author":"Sodsri","year":"2023","journal-title":"J. Clin. Med."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e36880_bib18","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.3899\/jrheum.130403","article-title":"PL-7 positive antisynthetase syndrome and pulmonary hypertension","volume":"40","author":"Foris","year":"2013","journal-title":"J. Rheumatol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e36880_bib19","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1093\/rheumatology\/keab142","article-title":"Anti-PL-7 antibody positive antisynthetase syndrome diagnosed after the onset of pulmonary hypertension and right-sided heart failure","volume":"60","author":"Okamoto","year":"2021","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36880_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12890-021-01399-5","article-title":"Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China","volume":"21","author":"Zhan","year":"2021","journal-title":"BMC Pulm. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e36880_bib21","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/rheumatology\/keab488","article-title":"Myositis specific antibodies are associated with isolated anti-Ro-52 associated interstitial lung disease","volume":"61","author":"Shao","year":"2022","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e36880_bib22","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10067-022-06404-8","article-title":"Analysis of the clinical features of antisynthetase syndrome: a retrospective cohort study in China","volume":"42","author":"Wang","year":"2023","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.heliyon.2024.e36880_bib23","article-title":"The clinical features and prognoses of anti-MDA5 and anti-aminoacyl-tRNA synthetase antibody double-positive dermatomyositis patients","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e36880_bib24","first-page":"kead638","article-title":"Antibody predictors of mortality and lung function trends in myositis spectrum interstitial lung disease","author":"Hannah","year":"2023","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e36880_bib25","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.chest.2023.01.031","article-title":"Diagnosis and management of myositis-associated lung disease","volume":"163","author":"Hallowell","year":"2023","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e36880_bib26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s11926-023-01105-w","article-title":"Intravenous immunoglobulin in idiopathic inflammatory myopathies: a practical guide for clinical use","volume":"25","author":"Gandiga","year":"2023","journal-title":"Curr. Rheumatol. Rep."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e36880_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102997","article-title":"Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: a systematic review and meta-analysis","volume":"21","author":"Goswami","year":"2022","journal-title":"Autoimmun. Rev."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e36880_bib28","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1021\/acs.jcim.5b00449","article-title":"Discovering new acetylcholinesterase inhibitors by mining the Buzhongyiqi decoction recipe data","volume":"55","author":"Cui","year":"2015","journal-title":"J. Chem. Inf. Model."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e36880_bib29","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s11655-020-3259-4","article-title":"Shenling Baizhu powder (.) ameliorates pi (Spleen)-Deficiency-Induced functional diarrhea in rats","volume":"27","author":"Xiao","year":"2021","journal-title":"Chin. J. Integr. Med."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024129118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024129118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:16:14Z","timestamp":1790543774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024129118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":29,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2405844024129118"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36880","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Case report: Antisynthetase syndrome with positive anti-PL7\/SSA\/RO52 antibodies","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36880","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e36880"}}